Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target EngagementSebastian Altenhöfer, Harald Schmidt|Antioxidants and Redox Signaling|2014Cited by 506
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptorsS P H Alexander, Scott A. Waldman, Christopher Southan et al.|British Journal of Pharmacology|2021Cited by 171
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptorsS P H Alexander, Scott A. Waldman, Doriano Fabbro et al.|British Journal of Pharmacology|2023Cited by 156
A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotectionFriederike Langhauser, Harald Schmidt|npj Systems Biology and Applications|2018Cited by 73
NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotypeMahmoud H. Elbatreek, Harald Schmidt|PLoS Biology|2020Cited by 51